drugset / Trial / NCT04023305
Sevoflurane PharmacokInetics in ARDS
Non-randomizedParallel-groupSingle-blindTreatment
Summary
The main objective of this study is to compare the pharmacokinetic models of sevoflurane-induced sedation during ARDS depending on the lung imaging phenotype (focal vs nonfocal phenotypes) The authors hypothesized that sevoflurane used for inhaled sedation could have distinct pharmacokinetic profiles depending on lung imaging phenotypes (focal vs nonfocal) during ARDS in ICU patients.
Timeline
- Start
- 2020-02-23
- Primary completion
- 2021-12-01
- Completion
- 2022-01-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Sevoflurane | Other / unclassified | — | Inhaled |